Related Experiment Video
Updated: Aug 22, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Steroid receptors in human breast cancer
Robert B Clarke1, Elizabeth Anderson, Anthony Howell
1CR-UK Department of Medical Oncology, Christie Hospital, Manchester, UK. rclarke@picr.man.ac.uk
Abstract:
Ovarian steroids, acting through nuclear receptors, are crucial players in normal breast development and cancer. Estrogen, in particular, is the focus of breast cancer therapies because tumours are often dependent on this steroid for growth. Recently, novel genes and/or protein isoforms of receptors for both estrogen and progesterone have been discovered, leading us to reappraise their roles in breast development and cancer. Recognition of changes in estrogen receptor biology that occur in the transition from normal development to cancer has emphasized its contribution to tumorigenesis. In addition, complex interactions with other signalling pathways, particularly growth factor pathways, have recently come to the forefront. These interactions might explain resistance to endocrine treatments and offer solutions in terms of novel therapeutic targets.
Insights
Ovarian steroids like estrogen are vital in breast cancer. New receptor discoveries prompt a re-evaluation of their roles and interactions, potentially revealing new therapeutic targets for endocrine resistance.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Ovarian steroids, particularly estrogen, are critical for breast development and cancer growth.
- Estrogen receptor (ER) signaling is a key target in breast cancer therapy.
- Tumor dependence on estrogen necessitates understanding ER biology in cancer progression.
Purpose of the Study:
- To reappraise the roles of estrogen and progesterone receptors in breast development and cancer.
- To investigate novel genes and protein isoforms of these receptors.
- To explore interactions between estrogen receptor biology and other signaling pathways.
Main Methods:
- Review of recent discoveries in nuclear receptor research.
- Analysis of estrogen receptor biology changes during tumorigenesis.
- Examination of crosstalk between growth factor pathways and estrogen signaling.
Main Results:
- Discovery of novel receptor genes and protein isoforms for estrogen and progesterone.
- Identification of critical changes in estrogen receptor biology during cancer development.
- Elucidation of complex interactions with growth factor signaling pathways.
Conclusions:
- New receptor insights necessitate a re-evaluation of ovarian steroid roles in breast cancer.
- Understanding ER biology shifts is crucial for comprehending tumorigenesis.
- Interactions with growth factor pathways offer potential targets for overcoming endocrine resistance.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Internal Receptors
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
